Skip to main content

Advertisement

SpringerLink
Log in

Techniques to assess the proliferative potential of brain tumors

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Assessment of brain tumor proliferative potential provides important prognostic information that supplements standard histopathologic grading. Many laboratories rely on mitotic figures to quantify the proliferative potential of brain tumors, but this conventional cellular proliferative index is subject to inter-observer variability and not consistently predictive for low-and high-grade tumors. Recent advancements in technology have made it possible to use proliferative indices as a standard supplement in pathology laboratories. Non-invasive tumor tissue measurements of cell proliferation can be performed using– bromodeoxyuridine labeling index (BrdU LI), flow cytometry (FCM), MIB-1 antibody to the Ki-67 antigen (MIB-1), proliferating cell nuclear antigen (PCNA), and argyrophilic nucleolar organizing regions (AgNOR). Each of these assays has been described in the literature with respect to its ability to predict tumor grade or outcome. At the present time MIB-1 and AgNOR are the simplest and most reliable of these techniques. In addition, advances in our understanding of the genetic alterations associated with proliferation promise to provide more specific markers of proliferative potential. Beyond the pathology laboratory, radiographic studies such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and most recently magnetic resonance spectroscopy (MRS) have been used as follow-up measures, assessing response to treatment and tumor recurrence, rather than as predictors of response to treatment. These radiographic tools, however, have the potential to provide an assessment of tumor proliferation without the need for invasive measures. In this article, we present a review of the current techniques utilized to understand the proliferative potential of brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. CM Abramovich RA. Prayson (1998) ArticleTitleMIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors Hum Pathol 29 1420–1427 Occurrence Handle10.1016/S0046-8177(98)90010-7 Occurrence Handle9865827

    Article  PubMed  Google Scholar 

  2. A. Ahyai (1998) ArticleTitleFlow cytometric analysis of cellular DNA content in human astrocytomas and oligodendrogliomas Neurosurg Rev 11 177–187 Occurrence Handle10.1007/BF01794685

    Article  Google Scholar 

  3. D Ancri JY. Basset (1980) ArticleTitleDiagnosis of cerebral metastases by thallium 201 Br J Radiol 53 443–453 Occurrence Handle7388277

    PubMed  Google Scholar 

  4. FG Barker MD Prados SM Chang et al. (1996) ArticleTitleBromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival Int J Radiat Oncol Biol Phys 34 803–808 Occurrence Handle10.1016/0360-3016(95)02027-6 Occurrence Handle8598356

    Article  PubMed  Google Scholar 

  5. KL Black T Emerick C Hoh et al. (1994) ArticleTitleThallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence Neurol Res 16 93–96 Occurrence Handle7914007

    PubMed  Google Scholar 

  6. AP Boon H. Sharif (1999) ArticleTitleValue of AgNOR method in predicting recurrence of meningioma J Clin Pathol 42 1002–1003

    Google Scholar 

  7. R Bravo R Frank PA Blundell et al. (1987) ArticleTitleCyclin/PCNA is the auxiliary protein of DNA polymerase-delta Nature 326 515–517 Occurrence Handle10.1038/326515a0 Occurrence Handle2882423

    Article  PubMed  Google Scholar 

  8. PC Burger T Shibata P. Kleihues (1986) ArticleTitleThe use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology Am J Surg Pathol 10 611–617 Occurrence Handle2428262

    PubMed  Google Scholar 

  9. JE Celis A. Celis (1985) ArticleTitleCell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase Proc Natl Acad Sci USA 82 3262–3266 Occurrence Handle2860667

    PubMed  Google Scholar 

  10. KG Cho T Hoshino T Nagashima et al. (1986) ArticleTitlePrediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling J Neurosurg 65 790–794 Occurrence Handle3772477

    PubMed  Google Scholar 

  11. R Chung J Whaley N Kley et al. (1991) ArticleTitleTP53 gene mutations and 17p deletions in human astrocytoma Genes Chromosomes Cancer 3 323–331 Occurrence Handle1686725

    PubMed  Google Scholar 

  12. Coons SW. (1996). Proliferation Markers in the Evaluation fo Gliomas, in Special Course AANP. Vancouver, Canada

  13. SW Coons JR Davis DL. Way (1988) ArticleTitleCorrelation of DNA content and histology in prognosis of astrocytomas Am J Clin Pathol 90 289–293 Occurrence Handle2843034

    PubMed  Google Scholar 

  14. Coons SW, Johnson PC, Pearl DK. (1994). Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas. Neurosurgery 35: 119–125; discussion 125–116

    Google Scholar 

  15. Coons SW, Johnson PC, Pearl DK. (1997). The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery 41: 878–884; discussion 884–875

    Google Scholar 

  16. Coons SW, Johnson PC, Pearl DK et al. (1994). Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery 34: 680–687; discussion 687

    Google Scholar 

  17. J Crocker JC Macartney PJ. Smith (1988) ArticleTitleCorrelation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin’s lymphomas J Pathol 154 151–156 Occurrence Handle10.1002/path.1711540207 Occurrence Handle3280766

    Article  PubMed  Google Scholar 

  18. JM Cunningham DW Kimmel BW Scheithauer et al. (1997) ArticleTitleAnalysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value J Neurosurg 86 121–130 Occurrence Handle8988090

    PubMed  Google Scholar 

  19. M Danova W Giaretti F Merlo et al. (1991) ArticleTitlePrognostic significance of nuclear DNA content in human neuroepithelial tumors Int J Cancer 48 663–667 Occurrence Handle2071227

    PubMed  Google Scholar 

  20. AO De Beeck P. Caillet-Fauquet (1997) ArticleTitleViruses and the cell cycle Prog Cell Cycle Res 3 1–19 Occurrence Handle9552402

    PubMed  Google Scholar 

  21. De Witte O, Levivier M, Violon P et al. (1996). Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 39: 470–476; discussion 476–477

    Google Scholar 

  22. F Dehghani W Schachenmayr A Laun et al. (1998) ArticleTitlePrognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases Acta Neuropathol (Berl) 95 493–504 Occurrence Handle10.1007/s004010050830

    Article  Google Scholar 

  23. D Delbeke C Meyerowitz RL Lapidus et al. (1995) ArticleTitleOptimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 47–52 Occurrence Handle7892494

    PubMed  Google Scholar 

  24. G. Di Chiro (1987) ArticleTitlePositron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool Invest Radiol 22 360–371 Occurrence Handle3496318

    PubMed  Google Scholar 

  25. G Di Chiro RL DeLaPaz RA Brooks et al. (1982) ArticleTitleGlucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1323–1329 Occurrence Handle6983044

    PubMed  Google Scholar 

  26. G Di Chiro J Hatazawa DA Katz et al. (1987) ArticleTitleGlucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study Radiology 164 521–526 Occurrence Handle3496626

    PubMed  Google Scholar 

  27. CM Dirven J Koudstaal JJ Mooij et al. (1998) ArticleTitleThe proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up J Neurooncol 37 9–16 Occurrence Handle10.1023/A:1005905009449 Occurrence Handle9525833

    Article  PubMed  Google Scholar 

  28. C Dowling AW Bollen SM Noworolski et al. (2001) ArticleTitlePreoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens AJNR Am J Neuroradiol 22 604–612 Occurrence Handle11290466

    PubMed  Google Scholar 

  29. MH Dreyling SK Bohlander MO Adeyanju et al. (1995) ArticleTitleDetection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization Cancer Res 55 984–988 Occurrence Handle7867008

    PubMed  Google Scholar 

  30. A Falini G Calabrese D Origgi et al. (1996) ArticleTitleProton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives J Neurol 243 706–714 Occurrence Handle10.1007/BF00873976 Occurrence Handle8923303

    Article  PubMed  Google Scholar 

  31. J Frahm H Bruhn W Hanicke et al. (1991) ArticleTitleLocalized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences J Comput Assist Tomogr 15 915–922 Occurrence Handle1939768

    PubMed  Google Scholar 

  32. DA Freeman L Wu AJ. Levine (1999) ArticleTitleFunctions of the MDM2 oncoprotein Cell Mol Life Sci 55 96–107 Occurrence Handle10.1007/s000180050273 Occurrence Handle10065155

    Article  PubMed  Google Scholar 

  33. A Freese D O’Rourke K Judy et al. (1994) ArticleTitleThe application of 5-bromodeoxyuridine in the management of CNS tumors J Neurooncol 20 81–95 Occurrence Handle10.1007/BF01057964 Occurrence Handle7807187

    Article  PubMed  Google Scholar 

  34. ML Friedlander DW Hedley IW. Taylor (1984) ArticleTitleClinical and biological significance of aneuploidy in human tumours J Clin Pathol 37 961–974 Occurrence Handle6381555

    PubMed  Google Scholar 

  35. T Fujimaki M Matsutani O Nakamura et al. (1991) ArticleTitleCorrelation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults Cancer 67 1629–1634 Occurrence Handle2001552

    PubMed  Google Scholar 

  36. V Ganju RB Jenkins JR O’Fallon et al. (1994) ArticleTitlePrognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers Cancer 74 920–927 Occurrence Handle8039120

    PubMed  Google Scholar 

  37. R Garcia A Bueno S Castanon et al. (1997) ArticleTitleStudy of the DNA content by flow cytometry and proliferation in 281 brain tumors Oncology 54 112–117 Occurrence Handle9075781

    PubMed  Google Scholar 

  38. J Gerdes H Lemke H Baisch et al. (1984) ArticleTitleCell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1710–1715 Occurrence Handle6206131

    PubMed  Google Scholar 

  39. HK Haapasalo PK Sallinen PT Helen et al. (1993) ArticleTitleComparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms J Pathol 171 207–214 Occurrence Handle10.1002/path.1711710309 Occurrence Handle7903983

    Article  PubMed  Google Scholar 

  40. PA Hall J Crocker A Watts et al. (1988) ArticleTitleA comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin’s lymphoma Histopathology 12 373–381 Occurrence Handle2453436

    PubMed  Google Scholar 

  41. A Hara N Sakai H Yamada et al. (1991) ArticleTitleRapid detection of proliferating potential in human brain tumors by nucleolar organizer region staining on squash preparations J Cancer Res Clin Oncol 117 510–514 Occurrence Handle10.1007/BF01613280 Occurrence Handle1720782

    Article  PubMed  Google Scholar 

  42. J He JJ Olson CD. James (1995) ArticleTitleLack of p16(INK4) or retinoblastoma protein (pRb), or amplification-associated overexpression of CDK4 is observed in distinct subsets of malignant glial cells Cancer Res 55 4833–4836 Occurrence Handle7585516

    PubMed  Google Scholar 

  43. JW Henson BL Schnitker KM Correa et al. (1995) ArticleTitleThe retinoblastoma gene is involved in malignant progression of astrocytomas Ann Neurol 36 714–721 Occurrence Handle10.1002/ana.410360505

    Article  Google Scholar 

  44. T Higa S Maetani K Yoichiro et al. (2001) ArticleTitleTI-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas Clin Nucl Med 26 119–124 Occurrence Handle10.1097/00003072-200102000-00006 Occurrence Handle11201468

    Article  PubMed  Google Scholar 

  45. T. Hoshino (1984) ArticleTitleA commentary on the biology and growth kinetics of low-grade and high- grade gliomas J Neurosurg 61 895–900 Occurrence Handle6491735

    PubMed  Google Scholar 

  46. T Hoshino D Ahn MD Prados et al. (1993) ArticleTitlePrognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling Int J Cancer 53 550–555 Occurrence Handle8382191

    PubMed  Google Scholar 

  47. T Hoshino T Nagashima KG Cho et al. (1986) ArticleTitleS phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine Int J Cancer 38 369–374 Occurrence Handle3527993

    PubMed  Google Scholar 

  48. T Hoshino T Nagashima JA Murovic et al. (1986) ArticleTitleProliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine Cancer 58 1466–1472 Occurrence Handle2427189

    PubMed  Google Scholar 

  49. T Hoshino M Prados CB Wilson et al. (1989) ArticleTitlePrognostic implications of the bromodeoxyuridine labeling index of human gliomas J Neurosurg 71 335–341 Occurrence Handle2549222

    PubMed  Google Scholar 

  50. T Hoshino LA Rodriguez KG Cho et al. (1988) ArticleTitlePrognostic implications of the proliferative potential of low-grade astrocytomas J Neurosurg 69 839–842 Occurrence Handle3193189

    PubMed  Google Scholar 

  51. WM Howell DA. Black (1980) ArticleTitleControlled silver-staining of nucleolus organizer regions with a protective colloidal developer: a 1-step method Experientia 36 1014–1015 Occurrence Handle10.1007/BF01953855 Occurrence Handle6160049

    Article  PubMed  Google Scholar 

  52. K Ichimura EE Schmidt HM Goike et al. (1996) ArticleTitleHuman glioblastomas with no alterations of the CDKN2 (p16, INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene Oncogene 13 1065–1072 Occurrence Handle8806696

    PubMed  Google Scholar 

  53. M Ide M Jimbo M Yamamoto et al. (1995) ArticleTitleGrowth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index Neurol Med Chir (Tokyo) 35 289–293

    Google Scholar 

  54. S Ito KL Chandler MD Prados et al. (1994) ArticleTitleProliferative potential and prognostic evaluation of low-grade astrocytomas J Neurooncol 19 1–9 Occurrence Handle10.1007/BF01051043 Occurrence Handle7815099

    Article  PubMed  Google Scholar 

  55. T Iuchi Y Iwadate H Namba et al. (1999) ArticleTitleGlucose and methionine uptake and proliferative activity in meningiomas Neurol Res 21 640–644 Occurrence Handle10555183

    PubMed  Google Scholar 

  56. E Jaros RH Perry L Adam et al. (1992) ArticleTitlePrognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours Br J Cancer 66 373–385 Occurrence Handle1503912

    PubMed  Google Scholar 

  57. J Jen W Harper SH Bigner et al. (1994) ArticleTitleDeletion of p16 and p15 genes in brain tumors Cancer Res 54 6353–6358 Occurrence Handle7987828

    PubMed  Google Scholar 

  58. K Kajiwara T Nishizaki T Orita et al. (1990) ArticleTitleSilver colloid staining technique for analysis of glioma malignancy J Neurosurg 73 113–117 Occurrence Handle1693670

    PubMed  Google Scholar 

  59. B Kaschten A Stevenaert B Sadzot et al. (1998) ArticleTitlePreoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 778–785 Occurrence Handle9591574

    PubMed  Google Scholar 

  60. S Khoshyomn H Maier T Morimura et al. (1993) ArticleTitleImmunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens Acta Neuropathol 86 582–589 Occurrence Handle10.1007/BF00294296

    Article  Google Scholar 

  61. Kim DK, Hoyt J, Bacchi C et al. (1993). Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins. Neurosurgery 33: 619–625; discussion 625–616

    Google Scholar 

  62. S Kosuda H Fujii S Aoki et al. (1994) ArticleTitlePrediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography Int J Radiat Oncol Biol Phys 30 1201–1206 Occurrence Handle7961030

    PubMed  Google Scholar 

  63. Kreipe H ZR, Fischer L et al. Immunocytochemical assessment of cell proliferation, In: Hofstadter FKR, Rushoff J (eds) Cell Proliferation Assessment in Oncology: VIrchow Arch, 1995, Vol 427, pp 324–326

  64. JV Lafuente K Alkiza JM Garibi et al. (2000) ArticleTitleBiologic parameters that correlate with the prognosis of human gliomas Neuropathology 20 176–183 Occurrence Handle10.1046/j.1440-1789.2000.00329.x Occurrence Handle11132932

    Article  PubMed  Google Scholar 

  65. KR Lamborn MD Prados SB Kaplan et al. (1999) ArticleTitleFinal report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients Cancer 85 925–935 Occurrence Handle10.1002/(SICI)1097-0142(19990215)85:4<925::AID-CNCR22>3.0.CO;2-Q Occurrence Handle10091772

    Article  PubMed  Google Scholar 

  66. G Landberg G. Roos (1991) ArticleTitleAntibodies to proliferating cell nuclear antigen as S phase probes in flow cytometric cell cycle analysis Cancer Res 51 4570–4574 Occurrence Handle1678682

    PubMed  Google Scholar 

  67. KS Lee T Hoshino LA Rodriguez et al. (1990) ArticleTitleBromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence Acta Neuropathol 80 311–317 Occurrence Handle10.1007/BF00294650 Occurrence Handle2399811

    Article  PubMed  Google Scholar 

  68. MD Linden FX Torres J Kubus et al. (1992) ArticleTitleClinical application of morphologic and immunocytochemical assessments of cell proliferation Am J Clin Pathol 97 S4–S13 Occurrence Handle1575220

    PubMed  Google Scholar 

  69. NS Litofsky TC Mix SP Baker et al. (1998) ArticleTitleKi-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: no prognostic significance Surg Neurol 50 579–585 Occurrence Handle10.1016/S0090-3019(97)00312-1 Occurrence Handle9870820

    Article  PubMed  Google Scholar 

  70. DN Louis S Edgerton AD Thor et al. (1991) ArticleTitleProliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study Acta Neuropathol 81 675–679 Occurrence Handle10.1007/BF00296379 Occurrence Handle1679278

    Article  PubMed  Google Scholar 

  71. A Maillo P Diaz A Blanco et al. (1999) ArticleTitleProportion of S phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors Cytometry 38 118–123 Occurrence Handle10.1002/(SICI)1097-0320(19990615)38:3<118::AID-CYTO5>3.0.CO;2-J Occurrence Handle10397331

    Article  PubMed  Google Scholar 

  72. PE McKeever DA Ross MS Strawderman et al. (1997) ArticleTitleA comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters J Neuropathol Exp Neurol 56 798–805 Occurrence Handle9210876

    PubMed  Google Scholar 

  73. PE McKeever MS Strawderman B Yamini et al. (1998) ArticleTitleMIB-1 proliferation index predicts survival among patients with grade II astrocytoma J Neuropathol Exp Neurol 57 931–936 Occurrence Handle9786243

    PubMed  Google Scholar 

  74. WE. Mercer (1998) ArticleTitleChecking on the cell cycle J Cell Biochem 30 50–54 Occurrence Handle10.1002/(SICI)1097-4644(1998)72:30/31+<50::AID-JCB8>3.0.CO;2-8

    Article  Google Scholar 

  75. A Merlo JG Herman L Mao et al. (1995) ArticleTitle5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 Nature Med 1 686–692 Occurrence Handle10.1038/nm0795-686 Occurrence Handle7585152

    Article  PubMed  Google Scholar 

  76. Montine TJ, Vandersteenhoven JJ, Aguzzi A et al. (1994). Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 34: 674–678; discussion 678–679

    Google Scholar 

  77. SJ Mork TB Halvorsen KF Lindegaard et al. (1986) ArticleTitleOligodendroglioma. Histologic evaluation and prognosis J Neuropathol Exp Neurol 45 65–78 Occurrence Handle3941327

    PubMed  Google Scholar 

  78. T Nagashima SJ DeArmond J Murovic et al. (1985) ArticleTitleImmunocytochemical demonstration of S phase cells by anti- bromodeoxyuridine monoclonal antibody in human brain tumor tissues Acta Neuropathol 67 155–159 Occurrence Handle10.1007/BF00688136 Occurrence Handle2992212

    Article  PubMed  Google Scholar 

  79. M Nakamura N Konishi S Tsunoda et al. (1997) ArticleTitleRetinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma Cancer 80 242–249 Occurrence Handle10.1002/(SICI)1097-0142(19970715)80:2<242::AID-CNCR12>3.0.CO;2-U Occurrence Handle9217037

    Article  PubMed  Google Scholar 

  80. S Nakasu M Nakajima K Matsumura et al. (1995) ArticleTitleMeningioma: proliferating potential and clinicoradiological features Neurosurgery 37 1049–1055 Occurrence Handle8584144

    PubMed  Google Scholar 

  81. T Nishi J Kuratsu H Takeshima et al. (1999) ArticleTitlePrognostic significance of the MIB-1 labeling index for patient with craniopharyngioma Int J Mol Med 3 157–161 Occurrence Handle9917523

    PubMed  Google Scholar 

  82. T Nishizaki N Ohshita Y Nagatsugu et al. (1993) ArticleTitleClinical evaluation of DNA index in human brain tumors J Neurooncol 17 9–13 Occurrence Handle10.1007/BF01054268 Occurrence Handle8120576

    Article  PubMed  Google Scholar 

  83. Y Ono T Tamiya T Ichikawa et al. (1996) ArticleTitleMalignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indeces J Neuropathol Exp Neurol 55 1026–1031 Occurrence Handle8857999

    PubMed  Google Scholar 

  84. N Oriuchi M Tamura T Shibazaki et al. (1993) ArticleTitleClinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities J Nucl Med 34 2085–2089 Occurrence Handle8254391

    PubMed  Google Scholar 

  85. D Ott J Hennig T. Ernst (1993) ArticleTitleHuman brain tumors: assessment with in vivo proton MR spectroscopy Radiology 186 745–752 Occurrence Handle8430183

    PubMed  Google Scholar 

  86. KH Plate J Ruschoff J Behnke et al. (1990) ArticleTitleProliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity Acta Neurochir 104 103–109 Occurrence Handle10.1007/BF01842827

    Article  Google Scholar 

  87. Raghavan R, Dickey WT, Jr., Margraf LR et al. (2000). Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children. Surg Neurol 54: 241–247; discussion 248

    Google Scholar 

  88. G Reifenberger L Liu K Ichimura et al. (1993) ArticleTitleAmplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations Cancer Res 53 2736–2739 Occurrence Handle8504413

    PubMed  Google Scholar 

  89. A Riccardi M Danova G Wilson et al. (1988) ArticleTitleCell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry Cancer Res 48 6238–6245 Occurrence Handle3167869

    PubMed  Google Scholar 

  90. Ritter AM, Sawaya R, Hess KR et al. (1994). Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme. Neurosurgery 35: 192–198; discussion 198

    Google Scholar 

  91. M Rodrigues AT Fonseca D Salgado et al. (1993) ArticleTitle99Tcm-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and 201Tl SPECT) Nucl Med Commun 14 1050–1060 Occurrence Handle8295760

    PubMed  Google Scholar 

  92. EJ Rushing DF Brown CL Hladik et al. (1998) ArticleTitleCorrelation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype Mod Pathol 11 464–470 Occurrence Handle9619600

    PubMed  Google Scholar 

  93. PK Sallinen HK Haapasalo T Visakorpi et al. (1994) ArticleTitlePrognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S phase fraction using archival paraffin-embedded samples J Pathol 174 275–282 Occurrence Handle10.1002/path.1711740407 Occurrence Handle7884589

    Article  PubMed  Google Scholar 

  94. I Salmon R. Kiss (1993) ArticleTitleRelationship between proliferative activity and ploidy level in a series of 530 human brain tumors, including astrocytomas, meningiomas, schwannomas, and metastases Hum Pathol 24 329–335 Occurrence Handle10.1016/0046-8177(93)90045-I Occurrence Handle8454277

    Article  PubMed  Google Scholar 

  95. D Schiffer A Chio MT Giordana et al. (1993) ArticleTitleProliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study Acta Neuropathol 85 495–502 Occurrence Handle10.1007/BF00230488 Occurrence Handle8098564

    Article  PubMed  Google Scholar 

  96. EE Schmidt K Ichimura G Reifenberger et al. (1994) ArticleTitleCDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas Cancer Res 54 6321–6324 Occurrence Handle7987821

    PubMed  Google Scholar 

  97. RB Schwartz BL Holman JF Polak et al. (1998) ArticleTitleDual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy J Neurosurg 89 60–68 Occurrence Handle9647173

    PubMed  Google Scholar 

  98. Shibuya M, Hoshino T, Ito S et al. (1992). Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30: 494–497; discussion 497–498

    Google Scholar 

  99. T Shiraishi K Tabuchi T Mineta et al. (1991) ArticleTitleNucleolar organizer regions in various human brain tumors J Neurosurg 74 979–984 Occurrence Handle2033460

    PubMed  Google Scholar 

  100. KK Shivji MK Kenny RD. Wood (1992) ArticleTitleProliferating cell nuclear antigen is required for DNA excision repair Cell 69 367–374 Occurrence Handle10.1016/0092-8674(92)90416-A Occurrence Handle1348971

    Article  PubMed  Google Scholar 

  101. JS Smith B Alderete Y Minn et al. (1999) ArticleTitleLocalization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene 18 4144–4152 Occurrence Handle10.1038/sj.onc.1202759 Occurrence Handle10435596

    Article  PubMed  Google Scholar 

  102. JS Smith RB. Jenkins (2000) ArticleTitleGenetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications Frontiers Bioscience 5 213–231

    Google Scholar 

  103. JS Smith I Tachibana SM Passe et al. (2001) ArticleTitlePTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme J Natl Cancer Inst 93 1246–1256 Occurrence Handle10.1093/jnci/93.16.1246 Occurrence Handle11504770

    Article  PubMed  Google Scholar 

  104. JS Smith XY Wang J Qian et al. (2000) ArticleTitleAmplification of platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features J Neuropathol Exp Neurol 59 495–503 Occurrence Handle10850862

    PubMed  Google Scholar 

  105. MT Smith CL Ludwig AD Godfrey et al. (1983) ArticleTitleGrading of oligodendrogliomas Cancer 52 2107–2114 Occurrence Handle6627218

    PubMed  Google Scholar 

  106. L Sokoloff M Reivich C Kennedy et al. (1977) ArticleTitleThe [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 897–916 Occurrence Handle864466

    PubMed  Google Scholar 

  107. FJ Stott JS Bates MC James et al. (1998) ArticleTitleThe alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2 EMBO J 17 5001–5014 Occurrence Handle10.1093/emboj/17.17.5001 Occurrence Handle9724636

    Article  PubMed  Google Scholar 

  108. K Sudha AK Karak MC Sharma et al. (1998) ArticleTitleAssessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts Indian J Pathol Microbiol 41 323–330 Occurrence Handle9805855

    PubMed  Google Scholar 

  109. T Tanaka T Takeuchi A Nishikawa et al. (1989) ArticleTitleNucleolar organizer regions in hepatocarcinogenesis induced by N-2- fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry Jpn J Cancer Res 80 1047–1051 Occurrence Handle2514166

    PubMed  Google Scholar 

  110. K Ueki Y Ono JW Henson et al. (1996) ArticleTitleCDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Res 56 150–153 Occurrence Handle8548755

    PubMed  Google Scholar 

  111. K Ueki MP Rubio V Ramesh et al. (1994) ArticleTitleMTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p Hum Molec Genet 3 1841–1845 Occurrence Handle7849711

    PubMed  Google Scholar 

  112. FT Vertosick SuffixJr. RG Selker SJ Grossman et al. (1994) ArticleTitleCorrelation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme Neurosurgery 34 396–401 Occurrence Handle8190213

    PubMed  Google Scholar 

  113. MC Vigliani A Chio T Pezzulo et al. (1994) ArticleTitleProliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance Tumori 80 295–300 Occurrence Handle7974802

    PubMed  Google Scholar 

  114. J Vion-Dury DJ Meyerhoff PJ Cozzone et al. (1994) ArticleTitleWhat might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 241 354–371 Occurrence Handle7931430

    PubMed  Google Scholar 

  115. H Wakimoto M Aoyagi T Nakayama et al. (1996) ArticleTitlePrognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas Cancer 77 373–380 Occurrence Handle10.1002/(SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO;2-Y Occurrence Handle8625247

    Article  PubMed  Google Scholar 

  116. Warburg O. The Metabolism of Tumors. Arnold Constable, London.

  117. Z Zaprianov K. Christov (1988) ArticleTitleHistological grading, DNA content, cell proliferation and survival of patients with astroglial tumors Cytometry 9 380–386 Occurrence Handle2841078

    PubMed  Google Scholar 

  118. P Zuber MF Hamou N. Tribolet Particlede (1988) ArticleTitleIdentification of proliferating cells in human gliomas using the monoclonal antibody Ki-67 Neurosurgery 22 364–368 Occurrence Handle2832782

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, Moffitt Hospital Room M779, Box 0112, San Francisco, CA, 94143-0112, USA

    Alfredo Quiñones-Hinojosa, Nader Sanai, Justin S. Smith & Michael W. McDermott

Authors
  1. Alfredo Quiñones-Hinojosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nader Sanai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Justin S. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael W. McDermott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfredo Quiñones-Hinojosa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quiñones-Hinojosa, A., Sanai, N., Smith, J.S. et al. Techniques to assess the proliferative potential of brain tumors. J Neurooncol 74, 19–30 (2005). https://doi.org/10.1007/s11060-004-5758-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-5758-0

Keywords

Search

Navigation